rapilysin
actavis group ptc ehf - reteplază - infarct miocardic - agenți antitrombotici - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
actilyse 50 mg
boehringer ingelheim pharma gmbh & co. kg - germania - alteplasum - pulb.+solv. pt. sol. inj./perf. - 50mg - antitrombotice enzime
gordox solutie injectabila 100000 uik
gedeon richter plc - aprotininum - solutie injectabila - 100000 uik
alka-prim 330 mg comprimate efervescente
pharmaceutical works polpharma s.a. - acid acetylsalicylicum - comprimate efervescente - 330 mg
ketorolac solutie injectabila 30 mg/ml
upm din borisov sad - ketorolacum - solutie injectabila - 30 mg/ml
actilyse 50 mg pulbere şi solvent pentru soluţie injectabilă/perfuzabilă
boehringer ingelheim international gmbh - alteplasum - pulbere şi solvent pentru soluţie injectabilă/perfuzabilă - 50 mg
sanovask 75 mg comprimate gastrorezistente
avexima sad - acid acetylsalicylicum - comprimate gastrorezistente - 75 mg
sanovask 50 mg comprimate gastrorezistente
avexima sad - acid acetylsalicylicum - comprimate gastrorezistente - 50 mg
sanovask 100 mg comprimate gastrorezistente
avexima sad - acid acetylsalicylicum - comprimate gastrorezistente - 100 mg
diclofenac de sodiu solutie injectabila 2,5%
belmedpreparati rup - diclofenacum - solutie injectabila - 2,5%